Filter Results
:
(5,947)
Show Results For
-
All HBS Web
(5,947)
- People (21)
- News (2,231)
- Research (2,807)
- Events (4)
- Multimedia (205)
- Faculty Publications (2,033)
Show Results For
-
All HBS Web
(5,947)
- People (21)
- News (2,231)
- Research (2,807)
- Events (4)
- Multimedia (205)
- Faculty Publications (2,033)
- February 2017 (Revised February 2021)
- Case
Hebrew SeniorLife: Next Steps
By: Regina E. Herzlinger, Carin-Isabel Knoop and Olivia Hull
The CEO of Hebrew SeniorLife is contemplating how to scale his highly successful but asset-intensive continuing care retirement community for elders. Among the strategies he is considering is an expansion to China; virtual web-based care; providing continuing care in...
View Details
- 06 Jun 2024
- Blog Post
Revolutionizing Wellness: Kate Twist (MBA 2008) Shapes the Future of Consumer Health Brands
$100mm to expand nationally, and has partnered with major retailers, developed products, launched campaigns, and digitized consumer experiences. With a passion for high-growth businesses and a commitment to helping underrepresented founders, Twist is re-imagining the...
View Details
- 2022
- Working Paper
Responding Strategically to Competitors' Failures: Evidence from Medical Device Recalls & New Product Submissions
By: George P. Ball, Jeffrey T. Macher and Ariel Dora Stern
Medical device firms operate at the frontiers of innovation. When functioning properly, innovative medical devices can prolong and improve lives; when malfunctioning, the same devices may harm patients and lead to product recalls. Product recalls create significant...
View Details
Keywords:
New Product Development;
Recalls;
Product Failures;
Medical Devices;
FDA;
Health Care;
Product Development;
Product;
Failure;
Competition;
Opportunities;
Medical Devices and Supplies Industry
Ball, George P., Jeffrey T. Macher, and Ariel Dora Stern. "Responding Strategically to Competitors' Failures: Evidence from Medical Device Recalls & New Product Submissions." Harvard Business School Working Paper, No. 19-028, September 2018. (Revised March 2022.)
- October 2013 (Revised January 2015)
- Case
The Slingshot: Improving Water Access
By: John A. Quelch, Margaret L. Rodriguez and Carin-Isabel Knoop
In 2012, over 750 million people around the globe lacked access to safe drinking water. Dean Kamen, inventor of the Segway, sought to bring fresh water to poor and rural areas with the Slingshot, a water purification device. Kamen's challenge was to identify ways to...
View Details
Keywords:
Water;
Public Health;
Health Care;
Slingshot;
Dean Kamen;
DEKA;
Coca-Cola;
Developing Markets;
Freestyle;
Safety;
Natural Environment;
Pollutants;
Health;
Distribution Channels;
Developing Countries and Economies;
Innovation and Invention;
Africa;
Latin America;
South America;
Asia
Quelch, John A., Margaret L. Rodriguez, and Carin-Isabel Knoop. "The Slingshot: Improving Water Access." Harvard Business School Case 514-007, October 2013. (Revised January 2015.)
- March 2010
- Teaching Note
Narayana Hrudayalaya Heart Hospital: Cardiac Care for the Poor (TN)
By: Tarun Khanna and V. Kasturi Rangan
Teaching Note for [505078].
View Details
- 12 Oct 2015
- News
Google Ventures: Big-time Consumer Health Is Still a Dream
- November–December 2015
- Article
Active Postmarketing Drug Surveillance for Multiple Adverse Events
By: Joel Goh, Margrét V. Bjarnadóttir, Mohsen Bayati and Stefanos A. Zenios
Postmarketing drug surveillance is the process of monitoring the adverse events of pharmaceutical or medical devices after they are approved by the appropriate regulatory authorities. Historically, such surveillance was based on voluntary reports by medical...
View Details
Keywords:
Drug Surveillance;
Health Care;
Stochastic Models;
Queueing;
Diffusion Approximation;
Brownian Motion;
Health Care and Treatment;
Analytics and Data Science;
Analysis
Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios. "Active Postmarketing Drug Surveillance for Multiple Adverse Events." Operations Research 63, no. 6 (November–December 2015): 1528–1546. (Finalist, 2012 INFORMS Health Applications Society Pierskalla Award.)
- 23 Apr 2014
- News
Are Electronic Cigarettes a Public Good or Health Hazard?
- 01 Sep 2007
- News
‘Redefining Health Care’: Medical Homes or Archipelagos to Navigate?
- 07 Feb 2007
- News
A Failing Transparency of Design Principles in Health Care?
- 2012
- Report
Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health
By: Mark R. Kramer, Kyle Peterson, Matthew Rehrig, Mike Stamp and Samuel Kim
Examples of how pharmaceutical and medical companies are addressing unmet health needs in low- and middle- income economies, creating shared value by providing products and services that tackle global health problems.
View Details
Keywords:
Shared Value;
Low- And Middle-income Economies;
Health Care and Treatment;
Global Range;
Pharmaceutical Industry;
Medical Devices and Supplies Industry
Kramer, Mark R., Kyle Peterson, Matthew Rehrig, Mike Stamp, and Samuel Kim. "Competing by Saving Lives: How Pharmaceutical and Medical Device Companies Create Shared Value in Global Health." Report, FSG, 2012.
- Article
Narrow Networks on the Health Insurance Marketplaces: Prevalence, Pricing, and the Cost of Network Breadth
By: Leemore S. Dafny, Igal Hendel, Victoria Marone and Christopher Ody
Anecdotal reports and systematic research highlight the prevalence of narrow-network plans on the Affordable Care Act’s health insurance Marketplaces. At the same time, Marketplace premiums in the period 2014–2016 were much lower than projected by the Congressional...
View Details
Dafny, Leemore S., Igal Hendel, Victoria Marone, and Christopher Ody. "Narrow Networks on the Health Insurance Marketplaces: Prevalence, Pricing, and the Cost of Network Breadth." Health Affairs 36, no. 9 (September 2017).
- February 2014
- Teaching Note
Community Health Workers in Zambia: Incentive Design and Management
By: Nava Ashraf and Kristin Johnson
Keywords:
Developing Countries and Economies;
Training;
Health Care and Treatment;
Compensation and Benefits;
Recruitment;
Selection and Staffing;
Mission and Purpose;
Non-Governmental Organizations;
Motivation and Incentives;
Health Industry;
Zambia
Ashraf, Nava, and Kristin Johnson. "Community Health Workers in Zambia: Incentive Design and Management." Harvard Business School Teaching Note 914-024, February 2014. (Request a courtesy copy.)
- 12 Jan 2015
- News
Why Online Retailers Are Starting to Care About Your Feelings
- December 2013 (Revised May 2021)
- Case
Paul Levy: Confronting a 'Corporate Campaign' (A)
Hospital CEO Paul Levy confronts an SEIU unionization drive via a "corporate campaign" aimed at undercutting the hospital's relationships with key internal and external constituencies. Having shepherded one of Boston's top teaching hospitals much of the way through a...
View Details
Keywords:
Dispute Resolution;
Corporate Campaign;
Negotiating Campaign;
Bargaining;
Health Care;
Hospitals;
Unions;
Health Care and Treatment;
Negotiation;
Strategy;
Negotiation Process;
Labor Unions;
Health Industry;
Boston
Sebenius, James K. "Paul Levy: Confronting a 'Corporate Campaign' (A)." Harvard Business School Case 914-020, December 2013. (Revised May 2021.)
- August 2018
- Article
The Impact of the Entry of Biosimilars: Evidence from Europe
By: Fiona M. Scott Morton, Ariel Dora Stern and Scott Stern
Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby...
View Details
Keywords:
Health Care;
Biosimilars;
Biologics;
Pharmaceutical Competition;
Healthcare Spending;
Innovation;
Health Care and Treatment;
Spending;
Market Entry and Exit;
Competition;
Innovation and Invention;
Pharmaceutical Industry;
United States;
Europe
Scott Morton, Fiona M., Ariel Dora Stern, and Scott Stern. "The Impact of the Entry of Biosimilars: Evidence from Europe." Review of Industrial Organization 53, no. 1 (August 2018): 173–210.
- 23 Aug 2020
- News
In the UK, She Leads the Search for a COVID Vaccine
Kate Bingham (MBA 1991) Kate Bingham (MBA 1991) When she was asked to chair the UK’s Vaccine Taskforce back in May, Kate Bingham (MBA 1991) paused. Despite nearly three decades of experience as a life sciences investor with SV Health...
View Details
- Article
Regulating Hospital Prices Based on Market Concentration Is Likely to Leave High-Price Hospitals Unaffected
By: Maximilian J. Pany, Michael E. Chernew and Leemore S. Dafny
Concern about high hospital prices for commercially insured patients has motivated several proposals to regulate these prices. Such proposals often limit regulations to highly concentrated hospital markets. Using a large sample of 2017 US commercial insurance claims,...
View Details
Keywords:
Health Care Providers;
Hospitals;
Insurance Market Regulation;
Price Regulation;
Markets;
Health Care and Treatment;
Cost;
Quality;
Insurance;
Price;
Governing Rules, Regulations, and Reforms
Pany, Maximilian J., Michael E. Chernew, and Leemore S. Dafny. "Regulating Hospital Prices Based on Market Concentration Is Likely to Leave High-Price Hospitals Unaffected." Health Affairs 40, no. 9 (September 2021): 1386–1394.
- 23 Jun 2016
- News